<DOC>
	<DOCNO>NCT00540969</DOCNO>
	<brief_summary>RATIONALE : Cryoablation kill cancer cell freeze . Radiation therapy use high-energy x-ray type radiation kill tumor cell . It yet know whether cryoablation effective external-beam radiation therapy treat painful bone metastasis . PURPOSE : This randomized phase III clinical trial study cryoablation see well work compare external-beam radiation therapy treat patient painful bone metastasis .</brief_summary>
	<brief_title>Cryoablation External-Beam Radiation Therapy Treating Patients With Painful Bone Metastases</brief_title>
	<detailed_description>OBJECTIVES : - To determine pain relief cancer patient painful metastatic disease involve bone follow treatment cryoablation compare radiotherapy ( RT ) . - To compare impact quality-of-life follow cryoablation RT patient painful metastatic disease measure use validated Brief Pain Inventory ( BPI ) Short Form ( SF ) -8 . - To determine change analgesic use follow therapy . - To determine frequency severity complication follow treatment painful metastasis involve bone either cryoablation RT . OUTLINE : This multicenter study . Patients stratify accord size indexing lesion ( ≤ 5 cm v &gt; 5 cm ) , location target lesion ( pelvis v extremity v vertebral body v ) , primary cancer type ( melanoma renal cell carcinoma v ) , severity pain ( i.e. , bad pain score last 24-hour period ) ( 4-6 v 7-10 ) . Patients randomize 1 2 treatment arm . - Arm I ( percutaneous cryoablation ) : Cryoprobes insert percutaneously CT scan ultrasound guidance , malignant soft tissue-bone interface . Patients undergo ablation use freeze-thaw-freeze cycle last approximately 10-5-10 minute , respectively . - Arm II ( external-beam radiotherapy ) : Patients undergo external-beam radiotherapy comprise either single 8 Gy dose 20 Gy/5 fraction administer 1 week . Patients contact via phone day 1 4 post treatment , weekly week 1-4 , every 2 week week 6-24 , every four week week 28-36 . Patients undergo pain pain interference daily life assessment baseline time point . Patients elect repeat treatment ( either radiotherapy cryoablation ) within first 6 week initial treatment remove study . Patients fail achieve 2-point reduction bad average pain ( 24-hour period ) week 6-20 initial treatment patient report return pain ( i.e. , pain ≥ bad pain 24-hour period report baseline ) 2 consecutive time point offer alternative treatment ( radiotherapy cryoablation , whichever patient randomize receive initial treatment ) * . NOTE : *Patients refuse receive alternative treatment take study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inclusion criterion : Histologically cytologically confirm solid tumor metastasis index lesion involve abut bone Index lesion bone destruction predominantly osteolytic nature assess CT image If nature metastatic disease previously document , index lesion treat require documentation ( i.e. , biopsy ) One primary painful metastatic site Additional less painful metastatic site may present Worst pain last 24 hour must ≥ 4 010 numeric scale Current analgesic therapy fail OR patient experience intolerable side effect Tumor appropriate radiotherapy determine participate radiation oncologist accessible cryoablation determine participate radiologist upon review ultrasound , CT scan , Xray , MRI examination Have complete chemotherapy , hormonal therapy , bisphosphonate therapy ≥ 4 week prior registration OR develop pain persistent pain stable chemotherapy , hormonal therapy , bisphosphonate therapy regimen period ≥ 4 week Exclusion criterion : Index lesion cause clinical radiographic evidence spinal cord cauda equina compression/effacement Index lesion involve skull Treatment painful lesion patient skull lesion exclude Index lesion evidence pathologic fracture impend fracture weightbearing bone ( e.g. , vertebral body , periacetabular region , femur , tibia ) &gt; 50 % loss cortical bone PATIENT CHARACTERISTICS : ECOG performance status 02 Life expectancy ≥ 2 month Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Inclusion criterion : See Disease Characteristics No concurrent medication know interfere platelet function coagulation ( e.g. , aspirin , ibuprofen , clopidogrel , warfarin ) medication discontinue appropriate time period base drug halflife know activity ( e.g. , aspirin 7 day ) patient randomize receive cryoablation Low molecular weight heparin preparation must discontinue 8 hour prior cryoablation At least 2 week since prior cytotoxic chemotherapy ( patient randomize receive cryoablation ) Exclusion criterion : Has undergone prior cryoablation radiotherapy index lesion Prior radiopharmaceutical therapy complete ≤ 4 week prior registration Initiation new chemotherapy ≤ 4 week prior registration Concurrent surgery involve treat lesion Anticipated treatment index lesion would require iceball formation within 0.5 cm spinal cord , brain , critical nerve structure , large abdominal vessel aorta IVC , bowel , bladder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>bone metastasis</keyword>
	<keyword>pain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>stage IV renal cell cancer</keyword>
</DOC>